(MXL) MaxLinear - Ratings and Ratios
SoC, Transceiver, Modem, RF, Mixed-Signal
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 71.4% |
| Value at Risk 5%th | 111% |
| Relative Tail Risk | -5.32% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.08 |
| Alpha | -44.43 |
| CAGR/Max DD | -0.24 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.399 |
| Beta | 2.329 |
| Beta Downside | 2.696 |
| Drawdowns 3y | |
|---|---|
| Max DD | 78.84% |
| Mean DD | 53.06% |
| Median DD | 57.16% |
Description: MXL MaxLinear November 12, 2025
MaxLinear (NASDAQ:MXL) designs and sells integrated communications system-on-chip (SoC) solutions that combine RF front-ends, high-performance analog, mixed-signal, DSP, security, data-compression, networking, and power-management functions. Its chips are embedded in 4G/5G base-station and backhaul equipment, optical transceivers, home-router Wi-Fi and wireline products, and broadband modems that meet DOCSIS, PON and DSL standards. The company reaches customers-including distributors, module makers, OEMs, and ODMs-through a direct sales force, third-party reps, and a global distributor network, and it has been operating since 2003 from its headquarters in Carlsbad, California.
Key recent metrics: FY 2023 revenue reached roughly $1.2 billion, with a gross margin of ~55% and cash on hand of $400 million, while R&D spending remained near 15% of revenue. The semiconductor segment is being driven by accelerating 5G rollout, increasing demand for edge-compute connectivity, and persistent supply-chain tightening that favors vendors with integrated, low-power SoCs. MaxLinear’s exposure to both wireless infrastructure and consumer broadband positions it to benefit from the broader industry trend of converging data-center and telecom traffic.
For a deeper quantitative view of MaxLinear’s valuation and risk profile, the ValueRay platform provides a concise, data-driven dashboard that’s worth a quick look.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (-179.6m TTM) > 0 and > 6% of Revenue (6% = 25.4m TTM) |
| FCFTA -0.04 (>2.0%) and ΔFCFTA 4.04pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 23.76% (prev 40.55%; Δ -16.80pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.02 (>3.0%) and CFO -18.6m > Net Income -179.6m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.55 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (87.2m) change vs 12m ago 3.70% (target <= -2.0% for YES) |
| Gross Margin 55.83% (prev 53.26%; Δ 2.57pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 49.71% (prev 43.98%; Δ 5.73pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -14.66 (EBITDA TTM -114.2m / Interest Expense TTM 10.5m) >= 6 (WARN >= 3) |
Altman Z'' -3.84
| (A) 0.12 = (Total Current Assets 284.1m - Total Current Liabilities 183.6m) / Total Assets 808.1m |
| (B) -0.60 = Retained Earnings (Balance) -485.5m / Total Assets 808.1m |
| (C) -0.18 = EBIT TTM -153.4m / Avg Total Assets 851.7m |
| (D) -1.41 = Book Value of Equity -485.3m / Total Liabilities 343.4m |
| Total Rating: -3.84 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 18.38
| 1. Piotroski 2.50pt |
| 2. FCF Yield -1.85% |
| 3. FCF Margin -7.02% |
| 4. Debt/Equity 0.31 |
| 5. Debt/Ebitda -0.28 |
| 6. ROIC - WACC (= -39.74)% |
| 7. RoE -36.61% |
| 8. Rev. Trend -85.51% |
| 9. EPS Trend -82.04% |
What is the price of MXL shares?
Over the past week, the price has changed by -2.60%, over one month by +9.33%, over three months by +10.22% and over the past year by -13.91%.
Is MXL a buy, sell or hold?
- Strong Buy: 4
- Buy: 0
- Hold: 7
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the MXL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.5 | 16.3% |
| Analysts Target Price | 20.5 | 16.3% |
| ValueRay Target Price | 15.2 | -13.6% |
MXL Fundamental Data Overview December 24, 2025
P/E Forward = 25.7732
P/S = 3.725
P/B = 3.3936
P/EG = 0.3937
Beta = 1.824
Revenue TTM = 423.4m USD
EBIT TTM = -153.4m USD
EBITDA TTM = -114.2m USD
Long Term Debt = 123.5m USD (from longTermDebt, last quarter)
Short Term Debt = 9.57m USD (from shortTermDebt, last quarter)
Debt = 145.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 31.9m USD (from netDebt column, last quarter)
Enterprise Value = 1.61b USD (1.58b + Debt 145.2m - CCE 113.2m)
Interest Coverage Ratio = -14.66 (Ebit TTM -153.4m / Interest Expense TTM 10.5m)
FCF Yield = -1.85% (FCF TTM -29.7m / Enterprise Value 1.61b)
FCF Margin = -7.02% (FCF TTM -29.7m / Revenue TTM 423.4m)
Net Margin = -42.43% (Net Income TTM -179.6m / Revenue TTM 423.4m)
Gross Margin = 55.83% ((Revenue TTM 423.4m - Cost of Revenue TTM 187.0m) / Revenue TTM)
Gross Margin QoQ = 56.58% (prev 56.00%)
Tobins Q-Ratio = 1.99 (Enterprise Value 1.61b / Total Assets 808.1m)
Interest Expense / Debt = 1.82% (Interest Expense 2.65m / Debt 145.2m)
Taxrate = -4.83% (negative due to tax credits) (2.10m / -43.4m)
NOPAT = -160.9m (EBIT -153.4m * (1 - -4.83%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.55 (Total Current Assets 284.1m / Total Current Liabilities 183.6m)
Debt / Equity = 0.31 (Debt 145.2m / totalStockholderEquity, last quarter 464.7m)
Debt / EBITDA = -0.28 (negative EBITDA) (Net Debt 31.9m / EBITDA -114.2m)
Debt / FCF = -1.07 (negative FCF - burning cash) (Net Debt 31.9m / FCF TTM -29.7m)
Total Stockholder Equity = 490.6m (last 4 quarters mean from totalStockholderEquity)
RoA = -22.23% (Net Income -179.6m / Total Assets 808.1m)
RoE = -36.61% (Net Income TTM -179.6m / Total Stockholder Equity 490.6m)
RoCE = -24.99% (EBIT -153.4m / Capital Employed (Equity 490.6m + L.T.Debt 123.5m))
RoIC = -26.21% (negative operating profit) (NOPAT -160.9m / Invested Capital 613.9m)
WACC = 13.53% (E(1.58b)/V(1.72b) * Re(14.60%) + D(145.2m)/V(1.72b) * Rd(1.82%) * (1-Tc(-0.05)))
Discount Rate = 14.60% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 3.31%
Fair Price DCF = unknown (Cash Flow -29.7m)
EPS Correlation: -82.04 | EPS CAGR: -38.37% | SUE: 0.66 | # QB: 0
Revenue Correlation: -85.51 | Revenue CAGR: -16.43% | SUE: 0.47 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.14 | Chg30d=-0.017 | Revisions Net=-1 | Analysts=11
EPS next Year (2026-12-31): EPS=0.75 | Chg30d=-0.040 | Revisions Net=-1 | Growth EPS=+159.6% | Growth Revenue=+18.2%
Additional Sources for MXL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle